Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03717896
PHASE2

Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis

Sponsor: Beth Israel Deaconess Medical Center

View on ClinicalTrials.gov

Summary

This is a randomized, double-blind, placebo-controlled trial to determine if administration of intravenous thiamine will lead to quicker resolution of acidosis in patients admitted to the hospital with diabetic ketoacidosis. The investigators will secondarily investigate whether thiamine improves cellular oxygen consumption, shortens intensive care unit (ICU) and hospital stay or decreases hospital resource utilization.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

102

Start Date

2018-11-21

Completion Date

2024-10-01

Last Updated

2026-06-23

Healthy Volunteers

No

Interventions

DRUG

200mg IV thiamine in 50mL 0.9% saline

Thiamine 200mg IV every 12 hours for 2 days

DRUG

Placebo

50mL 0.9% saline

Locations (1)

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States